2006
Physical activity in a cohort of HIV-positive and HIV-negative injection drug users
Smit E, Crespo C, Semba R, Jaworowicz D, Vlahov D, Ricketts E, Ramirez-Marrero F, Tang A. Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care 2006, 18: 1040-1045. PMID: 17012097, DOI: 10.1080/09540120600580926.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-positive participantsHIV-positive injection drug usersInjection drug useHIV-negativeVigorous activityPhysical activityDrug usersDrug usePaffenbarger Physical Activity QuestionnaireRecent injection drug usersHIV-negative injection drug usersIntravenous Experience cohortActive antiretroviral therapyCohort of HIVHIV-negative participantsPhysical Activity QuestionnairePhysical activity levelsAntiretroviral therapyHIV infectionViral loadHIV treatmentActivity QuestionnaireAnthropometric measurementsEnergy expenditure
2000
Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals
Thio C, Nolt K, Astemborski J, Vlahov D, Nelson K, Thomas D. Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals. Journal Of Clinical Microbiology 2000, 38: 575-577. PMID: 10655348, PMCID: PMC86151, DOI: 10.1128/jcm.38.2.575-577.2000.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHCV RNANegative participantsHepatitis C virus antibody testHuman immunodeficiency virus-infected individualsHepatitis C virus screeningThird-generation enzyme immunoassayHIV-negative participantsVirus-infected individualsHepatitis C virusInjection drug usersThird-generation assaysCOBAS AMPLICOR systemFalse-negative testsThird-generation testsFalse-negative resultsAcute infectionHIV infectionImmunodeficiency virusC virusAntibody formationAntibody testHCVVirus screeningAmplicor system
1996
Effect of Human Immunodeficiency Virus on Hepatitis C Virus Infection among Injecting Drug Users
Thomas D, Shih J, Alter H, Vlahov D, Cohn S, Hoover D, Cheung L, Nelson K. Effect of Human Immunodeficiency Virus on Hepatitis C Virus Infection among Injecting Drug Users. The Journal Of Infectious Diseases 1996, 174: 690-695. PMID: 8843204, DOI: 10.1093/infdis/174.4.690.Peer-Reviewed Original ResearchConceptsSerum HCV RNA concentrationHepatitis C virus infectionC virus infectionHCV RNA concentrationHIV infectionVirus infectionAlanine aminotransferaseDrug usersHuman immunodeficiency virus (HIV) immunosuppressionCD4 cells/HIV-negative patientsHIV-positive IDUsStage of HIVCD4 lymphocyte countHCV RNA levelsSerum ALT levelsHIV-negative participantsHuman immunodeficiency virusInjecting Drug UsersRNA concentrationSemiannual visitsALT levelsHCV infectionHIV RNAHIV seroconversion